| References: |
SL 0101-1 is a selective inhibitor of p90 Rsk (ribosomal S6 kinase) (IC50 = 89 nM for Rsk-2). This product does not inhibit upstream kinases such as MEK, Raf and PKC. SL 0101-1 inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line. For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, Please contact DC Chemicals. |
